Product How it works Pricing Blog FAQ About Contact
ACS

ACS (BME: ACS) financial statements

The consolidated income statement, balance sheet and cash flow statement of ACS for its last 6 fiscal years, as filed with the regulator, in millions of euros. At the end of fiscal 2025 it had €45,189m in total assets and €4,815m in equity.

Income statement

Item202520242023202220212020
Revenue€49,848m€41,633m€35,738m€33,615m€27,837m€29,305m
Finance costs€888.1m€843.3m€659.1m€484.2m€362.5m€376.7m
Profit before tax€1,662m€993.3m€1,127m€1,009m€57.5m€904.4m
Income tax€452.9m−€86.5m€199.1m€201.2m€789.4m€255.1m
Net profit€950.3m€827.6m€780.1m€668.2m€3,045m€574.0m
Earnings per share€3.69€3.23€3.00€2.50€10.74€1.95
Diluted earnings per share€3.69€3.23€3.00€2.50€10.74€1.95
Depreciation and amortisation€969.7m€866.2m€551.0m€620.8m€479.4m€876.3m

Balance sheet

Item202520242023202220212020
Total assets€45,189m€42,025m€36,498m€37,580m€35,664m€37,334m
Current assets€29,400m€26,949m€23,583m€25,159m€24,654m€24,315m
Inventories€873.8m€1,024m€790.0m€829.0m€742.1m€715.2m
Property, plant and equipment€2,278m€2,794m€1,592m€1,572m€1,465m€1,764m
Goodwill€5,053m€4,754m€2,734m€2,716m€2,672m€2,863m
Cash€12,100m€11,414m€9,087m€9,420m€11,253m€8,081m
Current liabilities€25,319m€23,116m€19,589m€19,720m€17,191m€22,452m
Equity€4,815m€4,714m€5,329m€5,547m€6,334m€3,528m
Equity including minorities€5,176m€5,115m€5,631m€6,376m€7,028m€4,276m
Minority interests€360.7m€400.7m€301.2m€828.5m€693.9m€747.4m

Cash flow statement

Item202520242023202220212020
Operating cash flow€3,047m€2,793m€1,502m€1,743m€203.1m€1,142m
Investing cash flow−€1,646m−€1,249m−€15.7m−€198.1m€3,398m€292.3m
Financing cash flow€47.6m€496.7m−€1,653m−€3,538m−€771.0m−€1,059m

Where each figure comes from

From the annual report ACS files every year in the European single electronic format (ESEF). The filing for each fiscal year: 2025 · 2024 · 2023 · 2022 · 2021. If an item is not tagged in the filing, it is not in the table. The summary of the last fiscal year is on the ACS page.

Information prepared from the accounts the company files with the regulator, for information purposes only. It is not financial advice or a recommendation to buy or sell. Updated on 12 November 2026.